ASBP Aspire BioPharma, Inc.
Company Analysis
Latest News
🟢 Aspire BioPharma is trading 5.7% up today amid possible biotech-sector tailwinds
Aspire BioPharma is trading at $8.89, up 5.71%, with biotech-sector sentiment a possible backdrop. - No company-specific announcement explaining the October...
🟢 Aspire BioPharma is trading 7.6% up today
Aspire BioPharma is trading at $8.78, up 7.60%, with no company-specific announcement identified to explain the October 15 move. - The latest company release...
🔴 Aspire BioPharma is trading 12% down today amid inflation-driven market weakness
Aspire BioPharma is trading 12.04% down at $7.20, amid a U.S. market selloff after hotter-than-expected September inflation revived higher-rate expectations;...
🟢 Aspire BioPharma is trading 7.33% up
Aspire BioPharma is trading at $8.35, up 7.33% during the October 13, 2026 session; no clear catalyst has been identified. - Its official press-release page...
🔴 Aspire BioPharma is trading 5.5% down — with no clear catalyst identified
Aspire BioPharma is trading 5.5% lower at $7.84, with no clear catalyst established. - The price is down from the October 9 close of $8.30, marking the largest...
🔴 Aspire BioPharma is trading 6.4% down in pre-market
Aspire BioPharma is trading 6.4% lower at $8.31 in pre-market, with no clear catalyst identified. - The supplied pre-market price compares with the October 5...
🔴 Aspire BioPharma is trading 7% down in after-hours trading
Aspire BioPharma is trading at $8.25, down 7.09%, with no clear company-specific announcement or fresh catalyst explaining the October 5 after-hours...
🟢 Aspire BioPharma is trading 5.9% up today amid broader-market gains
Aspire BioPharma is trading at $8.60, up 5.85%, with broader-market gains offering a possible tailwind. - No clear company-specific announcement on October 2...
🟢 Aspire BioPharma is trading 5.55% up with no clear catalyst identified
Aspire BioPharma is trading 5.55% up at $8.63, with no specific catalyst identified. - The latest reported company development was a September 29 change of...
🟢 Aspire BioPharma is trading 10.3% up
Aspire BioPharma is trading at $9.18, up 10.34% during the September 28 session, with the catalyst unclear. - No company-specific announcement explaining the...
🟢 Aspire BioPharma is trading 7% up today
Aspire BioPharma is trading up 6.97% at $8.90 on September 28, 2026, with no company-specific catalyst identified. - Latest identified company news predates...
🔴 Aspire BioPharma is trading 6.6% down today with no clear catalyst identified
Aspire BioPharma is trading at $8.13, down 6.55%, with no clear company-specific catalyst emerging for September 25, 2026. - The latest identifiable company...
🟢 Aspire BioPharma is trading 6.6% up today
Aspire BioPharma is trading 6.6% higher at $8.88, with no clear catalyst identified. - No new company-specific announcement, filing, earnings release, or...
🟢 Aspire BioPharma is trading 5.5% up today amid broad biotech strength
Aspire BioPharma is trading 5.52% higher at $8.65, likely reflecting broader biotech strength; no company-specific announcement, filing, earnings release, or...
🟢 Aspire BioPharma is trading 5% up in pre-market with broader biotech strength a possible factor
Aspire BioPharma is trading 5% higher at $8.61, with broader biotech strength the most plausible context, though the connection is unconfirmed. - It closed at...
🟢 Aspire BioPharma is trading 5% up in after-hours trading with no clear catalyst identified
Aspire BioPharma is trading 5% higher at $8.61 in after-hours trading, with no clear catalyst identified. - Shares closed at $8.20 on September 22, 2026. - No...
🔴 Aspire BioPharma is trading 5.4% down today — no clear catalyst identified
Aspire BioPharma is trading 5.4% down at $8.25 during September 22, 2026 trading, with no clear catalyst identified. - No credible September 22...
🟢 Aspire BioPharma is trading 8.27% up today as Fed decision eases policy uncertainty
Aspire BioPharma is trading 8.27% up now at $9.16 as U.S. markets rally following the Federal Reserve’s September 16, 2026 rate decision and easing policy...
🟢 Aspire BioPharma is trading 5% up today despite biotech weakness
Aspire BioPharma is trading 5% up at $8.61, though no clear company-specific catalyst was identified for September 16, 2026. - Latest located corporate...
🔴 Aspire BioPharma is trading 5.08% down today amid broad risk-off trading
Aspire BioPharma is trading 5.08% down at $8.41, with the decline appearing primarily linked to broad risk-off trading after no new company-specific catalyst...